| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Fortaz (ceftazidime) Injection, Fortaz (ceftazidime sodium) Injection, Ceptaz (ceftazidime) Injection (L-arginine formulation), GlaxoSmithKline NDA 50-578/S-040, 50-634/S-012 & 50-646/S14 3/29/02 4/8/02 3/29/02 Fortaz (ceftazidime sodium) Injection Fortaz (ceftazidime) Injection, GlaxoSmithKline NDA 50-578/S-042 & 50-634/S-014 CEFTAZIDIME Injection 1GM/VIAL TAZICEF ABBOTT 064032 CEFTAZIDIME Injection 1GM/VIAL TAZICEF ABBOTT 064032 CEFTAZIDIME Injection 2GM/VIAL TAZICEF ABBOTT 062662 CEFTAZIDIME Injection 2GM/VIAL TAZICEF ABBOTT 062662 CEFTAZIDIME Injection 500MG/VIAL TAZICEF ABBOTT 062662 CEFTAZIDIME Injection 6GM/VIAL TAZICEF ABBOTT 050578 CEFTAZIDIME Injection 1GM/VIAL FORTAZ GLAXOSMITHKLINE 050578 CEFTAZIDIME Injection 2GM/VIAL FORTAZ GLAXOSMITHKLINE 050578 CEFTAZIDIME Injection 500MG/VIAL FORTAZ GLAXOSMITHKLINE 050578 CEFTAZIDIME Injection 6GM/VIAL FORTAZ GLAXOSMITHKLINE 062640 CEFTAZIDIME Injection 1GM/VIAL TAZIDIME LILLY 062655 CEFTAZIDIME Injection 1GM/VIAL TAZIDIME LILLY 062655 CEFTAZIDIME Injection 2GM/VIAL TAZIDIME LILLY 062640 CEFTAZIDIME Injection 2GM/VIAL TAZIDIME LILLY 062640 CEFTAZIDIME Injection 500MG/VIAL TAZIDIME LILLY 050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 10GM/VIAL CEPTAZ GLAXOSMITHKLINE 050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 1GM/VIAL CEPTAZ GLAXOSMITHKLINE 050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 2GM/VIAL CEPTAZ GLAXOSMITHKLINE 063221 CEFTAZIDIME SODIUM Injection 10MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER BAXTER 063221 CEFTAZIDIME SODIUM Injection 20MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER BAXTER 063221 CEFTAZIDIME SODIUM Injection 40MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER BAXTER 050634 CEFTAZIDIME SODIUM Injection 20MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE 050634 CEFTAZIDIME SODIUM Injection 40MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE |
|
© 2009 Betterchem.com
|